• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anika Therapeutics Inc. - Common Stock (NQ:ANIK)

11.00 +0.31 (+2.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 87,771
Open 10.75
Bid (Size) 10.47 (4)
Ask (Size) 17.53 (2)
Prev. Close 10.69
Today's Range 10.75 - 11.12
52wk Range 10.47 - 28.60
Shares Outstanding 14,828,456
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
July 16, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 03, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire

Performance

YTD
-32.1%
-32.1%
1 Month
+0.7%
+0.7%
3 Month
-22.5%
-22.5%
6 Month
-33.3%
-33.3%
1 Year
-60.7%
-60.7%

More News

Read More
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
What's Next: Anika Therapeutics's Earnings Preview
October 30, 2024
Via Benzinga
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Earnings Scheduled For May 9, 2025
May 09, 2025
Via Benzinga
A Glimpse of Anika Therapeutics's Earnings Potential
May 08, 2025
Via Benzinga
Anika to Participate in the Sidoti Virtual Investor Conference
May 07, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
April 25, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 07, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Microsoft To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Thursday
March 13, 2025
Via Benzinga
US Stocks Likely To Open Lower After A Brief Respite: 'Add Exposure To Equities' Amid Pullback, Says Expert
March 13, 2025
Via Benzinga
Topics Economy
Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
March 13, 2025
Via Benzinga
Earnings Scheduled For March 12, 2025
March 12, 2025
Via Benzinga
Anika Completes Divestiture of Parcus Medical
March 07, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika to Issue Fourth Quarter and Year-End 2024 Financial Results on Wednesday, March 12, 2025
February 26, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika To Present at the Canaccord Genuity 2025 Musculoskeletal Conference
February 25, 2025
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
December 23, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika To Participate in December 2024 Investor Conferences
November 22, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via Benzinga
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
October 31, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Announces Third Quarter 2024 Results Conference Call Date
October 17, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 04, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2024
From Anika Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Anika Therapeutics Inc. - Common Stock publicly traded?
Yes, Anika Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Anika Therapeutics Inc. - Common Stock trade on?
Anika Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Anika Therapeutics Inc. - Common Stock?
The ticker symbol for Anika Therapeutics Inc. - Common Stock is ANIK on the Nasdaq Stock Market
What is the current price of Anika Therapeutics Inc. - Common Stock?
The current price of Anika Therapeutics Inc. - Common Stock is 11.00
When was Anika Therapeutics Inc. - Common Stock last traded?
The last trade of Anika Therapeutics Inc. - Common Stock was at 07/22/25 04:00 PM ET
What is the market capitalization of Anika Therapeutics Inc. - Common Stock?
The market capitalization of Anika Therapeutics Inc. - Common Stock is 163.11M
How many shares of Anika Therapeutics Inc. - Common Stock are outstanding?
Anika Therapeutics Inc. - Common Stock has 163M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap